Literature DB >> 9038851

Use of labeling pattern of liver glutamate to calculate rates of citric acid cycle and gluconeogenesis.

V Large1, H Brunengraber, M Odeon, M Beylot.   

Abstract

The use of the labeling pattern of hepatic glutamate during infusion of L-[3-13C]- or [3-14C]lactate to calculate rates of citric acid cycle activity and gluconeogenesis has been proposed. We tested the validity of this approach by perfusing isolated rat livers (48 h starved) with pyruvate and lactate (10% enriched with [3-13C]lactate) without (control) or with infusion of glucagon (to inhibit pyruvate kinase), mercaptopicolinate (to inhibit phosphoenolpyruvate carboxykinase), or dichloroacetate (to stimulate pyruvate dehydrogenase). Compared with control experiments, glucagon increased glucose output (P < 0.05) and decreased the calculated flux through pyruvate kinase (P < 0.05). Mercaptopicolinate almost totally suppressed glucose production and dramatically reduced the calculated gluconeogenic rate and flux through phosphoenolpyruvate carboxykinase (P < 0.001). Dichloroacetate moderately increased the calculated flux through pyruvate dehydrogenase (P < 0.05). In experiments with perfused livers from fed rats, the calculated gluconeogenic rate and flux through phosphoenolpyruvate carboxykinase were very low compared with control experiments (P < 0.001), whereas the pyruvate dehydrogenase flux was increased (P < 0.05). Therefore, the expected modifications of the citric acid cycle activity and gluconeogenic rate were clearly detected using the labeling pattern of glutamate to calculate these metabolic rates. Except for the perfusions with mercaptopicolinate, the dilution by isotopic exchange in the oxaloacetate pool calculated from the model agreed with the actual dilution of enrichment between liver pyruvate and phosphoenolpyruvate. The present results support the validity of this approach to trace liver metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038851     DOI: 10.1152/ajpendo.1997.272.1.E51

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  In Vivo Estimates of Liver Metabolic Flux Assessed by 13C-Propionate and 13C-Lactate Are Impacted by Tracer Recycling and Equilibrium Assumptions.

Authors:  Clinton M Hasenour; Mohsin Rahim; Jamey D Young
Journal:  Cell Rep       Date:  2020-08-04       Impact factor: 9.423

Review 2.  Hepatic glucose and lipid metabolism.

Authors:  John G Jones
Journal:  Diabetologia       Date:  2016-04-05       Impact factor: 10.122

3.  Multi-omics-based label-free metabolic flux inference reveals obesity-associated dysregulatory mechanisms in liver glucose metabolism.

Authors:  Saori Uematsu; Satoshi Ohno; Kaori Y Tanaka; Atsushi Hatano; Toshiya Kokaji; Yuki Ito; Hiroyuki Kubota; Ken-Ichi Hironaka; Yutaka Suzuki; Masaki Matsumoto; Keiichi I Nakayama; Akiyoshi Hirayama; Tomoyoshi Soga; Shinya Kuroda
Journal:  iScience       Date:  2022-02-04

Review 4.  Lipid alterations in chronic liver disease and liver cancer.

Authors:  Bichitra Paul; Monika Lewinska; Jesper B Andersen
Journal:  JHEP Rep       Date:  2022-03-26

5.  Noninvasive measurement of murine hepatic acetyl-CoA ¹³C-enrichment following overnight feeding with ¹³C-enriched fructose and glucose.

Authors:  Filipa Carvalho; Joao Duarte; Ana Rita Simoes; Pedro F Cruz; John G Jones
Journal:  Biomed Res Int       Date:  2013-06-10       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.